Clinical Trials
4 trialsNCT04222972 2026-03-05
AcceleRET-Lung
Hoffmann-La Roche
Phase 3 Terminated
NCT04697446 2021-08-10
External Control, Observational, Retrospective Study Comparing Pralsetinib to Best Available Therapy in Patients With RET-Fusion Positive NSCLC
Blueprint Medicines Corporation
Unknown
NCT01331863 2020-09-09
TRACHBRONCAR
Assistance Publique - Hôpitaux de Paris
Phase 1/2 Completed
NCT02913365 2016-09-23
Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis
Université de Sherbrooke
Unknown